Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-17 · accession 0000914475-24-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-21 | 2024-05-17 | NBIX | SHERWIN STEPHEN A | Dir | M - OptEx | $0.00 | +4,199 | 26.5K | +19% | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | SHERWIN STEPHEN A | Dir | M - OptEx | $0.00 | -4,199 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-17 | M | A | 4,199 | $0.00 | 26,504 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2024-05-17 | M | D | 4,199 | $0.00 | 0 | D | — · — to — | 4,199 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. (F2) This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested. |